Bruderman Asset Management, LLC West Pharmaceutical Services Inc Transaction History

Bruderman Asset Management, LLC

$55.7 Million
Q2 2022

A detailed history of Bruderman Asset Management, LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Bruderman Asset Management, LLC holds 1,429 shares of WST stock, worth $470,698. This represents 0.78% of its overall portfolio holdings.

Number of Shares

1,429

Previous 1,384 3.25%

Holding current value

$470,698

Previous $570,000 24.21%

% of portfolio

0.78%

Previous 0.86%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$280.61 - $420.45 $12,627 - $18,920	45 Added 3.25%	1,429 $432,000
Q1 2022 May 13, 2022	BUY	$357.49 - $445.92 $38,966 - $48,605	109 Added 8.55%	1,384 $570,000
Q4 2021 Feb 14, 2022	SELL	$402.25 - $471.34 $290,826 - $340,778	-723 Reduced 36.19%	1,275 $597,000
Q3 2021 Oct 13, 2021	BUY	$363.01 - $468.47 $67,882 - $87,603	187 Added 10.33%	1,998 $848,000
Q2 2021 Jul 14, 2021	BUY	$284.77 - $363.2 $29,046 - $37,046	102 Added 5.97%	1,811 $651,000

Q1 2021 Apr 23, 2021	SELL	$257.29 - $307.53 $38,078 - $45,514	-148 Reduced 7.97%	1,709 $481,000
Q4 2020 Jan 29, 2021	BUY	$261.16 - $301.66 $69,468 - $80,241	266 Added 16.72%	1,857 $526,000
Q3 2020 Oct 14, 2020	SELL	$224.99 - $288.02 $3,824 - $4,896	-17 Reduced 1.06%	1,591 $437,000
Q2 2020 Aug 06, 2020	BUY	$149.8 - $227.17 $240,878 - $365,289	1,608 New	1,608 $362,000
Q2 2019 Aug 12, 2019	SELL	$111.27 - $125.15 $121,951 - $137,164	-1,096 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$94.53 - $110.2 $103,604 - $120,779	1,096 New	1,096 $121,000

Others Institutions Holding WST

# of Institutions

824

Shares Held

64.4M

Call Options Held

184K

Put Options Held

312K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.4B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruderman Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruderman Asset Management, LLC with notifications on news.

Account

Bruderman Asset Management, LLC West Pharmaceutical Services Inc Transaction History